Clinical Challenges: First-Line Options for Metastatic RCC

(MedPage Today) -- Fifteen years ago, the average patient who walked into an oncology clinic with metastatic renal cell carcinoma (RCC) would be told that they had a median survival of 12 to 18 months.
"This was an era where clinicians were using...